Ruxin (Beijing) Medical Systems Co., Ltd. (hereinafter referred to as Ruxin Technology) through careful and rigorous preparations, under the guidance of relevant leaders and experts, through the joint efforts and collaboration of personnel from various departments, On November 30, 2020, it obtained the "Medical Device Production License" issued by Beijing Drug Administration (Beijing Food and Drug Administration No. 20200089). This is another breakthrough after obtaining the "Registration Certificate for Class III Medical Devices of the People's Republic of China" (National Machinery Note 20203080594) and EU CE certification in the early stage. It fully shows that Ruxin Technology has once again been recognized by government authorities and relevant international agencies in the research and development, production, and sales of innovative respiratory and airway management medical devices, and will continue to work hard to improve domestic and foreign ICU airways in the future. Lay a good foundation for management skills.

    From November 17th to 18th, 2020, Ruxin Technology accepted the on-site inspection of the quality system of medical device production license by the Beijing Municipal Drug Administration.

  According to the “Regulations on the Supervision and Administration of Medical Devices” and the requirements of relevant laws and regulations, the expert team of the Beijing Municipal Drug Administration Many contents were checked. After on-site inspection and evaluation, after Ruxin Technology rectified 5 items of nonconformity, the experts agreed that Ruxin Technology meets the production conditions of medical devices and relevant legal requirements, and the conclusions of the medical device on-site verification are passed.